Bitcoin price today: hits record high over $124k on rate cut bets, corporate cheer
LINCOLN, NE - National Research Corporation (NASDAQ:NRC), a $245 million market cap company specializing in commercial physical and biological research, has announced key changes in its executive management through an 8-K filing with the Securities and Exchange Commission. The company, which generates annual revenues of $143 million with an impressive 60% gross profit margin, is currently trading significantly below its InvestingPro Fair Value.
On Monday, the company’s board of directors appointed Michael D. Hays (LON:HAYS), the current Chief Executive Officer (CEO), to also serve as the principal financial officer. Hays, 70, who founded National Research Corporation in 1981, will maintain his role as CEO until Trent (NSE:TREN) Green assumes the position on June 1, 2025. Hays has a longstanding tenure with the company, having served as President at various times since its inception, and prior to that, he was a Vice President and director at SRI Research Center, Inc. (now known as the Gallup Organization). According to InvestingPro data, management has been actively buying back shares, demonstrating confidence in the company’s future despite the stock’s 69% decline over the past year. The company maintains a healthy P/E ratio of 10.2 and offers a dividend yield of 4.7%.
In addition, the board named Jordan N. Freeman as the new Chief Accounting Officer (CAO). Freeman, 37, joined the company in April 2025 as Vice President, Finance Operations. Her professional background includes significant experience in accounting and finance, having held various roles at Nelnet (NYSE:NNI), Inc., a publicly traded company on the New York Stock Exchange. Freeman’s responsibilities at Nelnet ranged from Director of Accounting to Segment Controller, providing her with a comprehensive understanding of accounting operations. She is also a Certified Public Accountant with previous experience at HBE Becker Meyer Love, LLP, and as a Senior Audit Associate with Deloitte & Touche LLP.
The appointments of Hays and Freeman did not come with any changes to their compensation. These executive shifts come as part of National Research Corporation’s ongoing management structure adjustments. The information disclosed in this article is based on the latest SEC filing by National Research Corporation.
In other recent news, National Research Corporation has disclosed significant changes to its executive compensation structure, aligning it more closely with shareholder interests. Helen L. Hrdy, the Chief Operating Officer, has been granted 100,000 shares of common stock with specific conditions, along with a cash bonus based on the stock’s closing price. These compensation adjustments also apply to Andrew Monnich, Chief Corporate Development Officer, as both executives have forfeited their participation in the 2024 long-term cash incentive plan. Additionally, NRC Health announced a quarterly cash dividend of $0.12 per share, payable to shareholders of record by March 28, 2025. This dividend reflects the company’s commitment to returning value to its shareholders and confidence in its financial strength. In a strategic move, UC Health has partnered with NRC Health to utilize its Market Insights and Community Insights solutions, aiming to enhance patient care through data-driven strategies. This collaboration is expected to provide UC Health with deeper insights into consumer behaviors and expectations in the healthcare sector. NRC Health’s tools are designed to collect extensive consumer feedback, aiding healthcare organizations in making informed business decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.